Fresh Tracks Therapeutics (FRTX) Competitors $0.72 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends FRTX vs. SLGL, SYBX, GOVX, HCWB, TLPH, MRNS, CMMB, AIM, NLSP, and TENXShould you be buying Fresh Tracks Therapeutics stock or one of its competitors? The main competitors of Fresh Tracks Therapeutics include Sol-Gel Technologies (SLGL), Synlogic (SYBX), GeoVax Labs (GOVX), HCW Biologics (HCWB), Talphera (TLPH), Marinus Pharmaceuticals (MRNS), Chemomab Therapeutics (CMMB), AIM ImmunoTech (AIM), NLS Pharmaceutics (NLSP), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical products" industry. Fresh Tracks Therapeutics vs. Sol-Gel Technologies Synlogic GeoVax Labs HCW Biologics Talphera Marinus Pharmaceuticals Chemomab Therapeutics AIM ImmunoTech NLS Pharmaceutics Tenax Therapeutics Sol-Gel Technologies (NASDAQ:SLGL) and Fresh Tracks Therapeutics (NASDAQ:FRTX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability. Do insiders & institutionals have more ownership in SLGL or FRTX? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 25.0% of Fresh Tracks Therapeutics shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by company insiders. Comparatively, 0.2% of Fresh Tracks Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger valuation & earnings, SLGL or FRTX? Fresh Tracks Therapeutics has higher revenue and earnings than Sol-Gel Technologies. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Fresh Tracks Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$1.55M9.17-$27.24M-$0.54-0.94Fresh Tracks Therapeutics$8.01M0.54-$5.69M-$1.41-0.51 Do analysts rate SLGL or FRTX? Sol-Gel Technologies currently has a consensus target price of $5.00, indicating a potential upside of 880.20%. Given Sol-Gel Technologies' higher possible upside, analysts clearly believe Sol-Gel Technologies is more favorable than Fresh Tracks Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Fresh Tracks Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is SLGL or FRTX more profitable? Fresh Tracks Therapeutics has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -227.40%. Fresh Tracks Therapeutics' return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-227.40% -39.95% -33.69% Fresh Tracks Therapeutics N/A N/A N/A Which has more risk and volatility, SLGL or FRTX? Sol-Gel Technologies has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Comparatively, Fresh Tracks Therapeutics has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Does the MarketBeat Community believe in SLGL or FRTX? Sol-Gel Technologies received 149 more outperform votes than Fresh Tracks Therapeutics when rated by MarketBeat users. Likewise, 63.40% of users gave Sol-Gel Technologies an outperform vote while only 0.00% of users gave Fresh Tracks Therapeutics an outperform vote. CompanyUnderperformOutperformSol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Fresh Tracks TherapeuticsOutperform VotesNo VotesUnderperform Votes1100.00% Does the media refer more to SLGL or FRTX? In the previous week, Sol-Gel Technologies' average media sentiment score of 0.00 equaled Fresh Tracks Therapeutics'average media sentiment score. Company Overall Sentiment Sol-Gel Technologies Neutral Fresh Tracks Therapeutics Neutral SummarySol-Gel Technologies beats Fresh Tracks Therapeutics on 9 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Fresh Tracks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FRTX vs. The Competition Export to ExcelMetricFresh Tracks TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.30M$3.14B$5.40B$8.53BDividend YieldN/A1.77%5.15%4.14%P/E Ratio-0.5112.02113.7615.14Price / Sales0.54332.371,483.0493.53Price / CashN/A148.6339.7134.04Price / Book0.434.024.665.01Net Income-$5.69M-$42.25M$119.06M$225.46M7 Day Performance1.41%8.08%0.79%0.37%1 Month Performance-2.70%8.72%5.65%3.57%1 Year Performance-20.00%32.11%36.80%29.42% Fresh Tracks Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FRTXFresh Tracks TherapeuticsN/A$0.72flatN/A-21.3%$4.30M$8.01M-0.5120SLGLSol-Gel Technologies2.4697 of 5 stars$0.62-4.7%$5.00+713.0%-60.8%$17.13M$6.56M-1.1450Gap UpSYBXSynlogic2.7858 of 5 stars$1.46+2.8%$30.00+1,954.8%-16.6%$17.09M$3.17M-0.2280News CoveragePositive NewsGOVXGeoVax Labs3.2243 of 5 stars$2.01+1.0%$12.67+530.2%-74.9%$16.86M$300,677.000.0017HCWBHCW Biologics1.1279 of 5 stars$0.44-2.2%N/A-73.0%$16.68M$3.92M-0.4240Short Interest ↓Gap UpTLPHTalphera2.4262 of 5 stars$0.96-4.0%$4.50+368.8%N/A$16.31M$398,000.00-1.5019MRNSMarinus Pharmaceuticals4.1193 of 5 stars$0.29-21.6%$6.07+1,993.6%-95.1%$15.97M$30.99M-0.11110Upcoming EarningsAnalyst ForecastHigh Trading VolumeCMMBChemomab Therapeutics2.5672 of 5 stars$1.44-5.9%$5.67+293.5%+89.0%$15.91MN/A-1.2620Gap DownAIMAIM ImmunoTech1.3085 of 5 stars$0.27flat$3.00+1,011.1%-43.7%$15.84M$201,000.00-0.4720NLSPNLS Pharmaceutics0.2288 of 5 stars$4.13+0.5%N/A+408.8%$15.78MN/A0.006Gap UpTENXTenax Therapeutics3.2034 of 5 stars$4.59-5.7%$170.67+3,618.2%-69.7%$15.65MN/A0.009News Coverage Related Companies and Tools Related Companies Sol-Gel Technologies Alternatives Synlogic Alternatives GeoVax Labs Alternatives HCW Biologics Alternatives Talphera Alternatives Marinus Pharmaceuticals Alternatives Chemomab Therapeutics Alternatives AIM ImmunoTech Alternatives NLS Pharmaceutics Alternatives Tenax Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FRTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh Tracks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresh Tracks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FRTX Stock Alerts